Zobrazeno 1 - 10
of 233
pro vyhledávání: '"fibrosing interstitial lung disease"'
Autor:
Yusuke Ushio, Risa Wakiya, Tomohiro Kameda, Shusaku Nakashima, Hiromi Shimada, Taichi Miyagi, Koichi Sugihara, Rina Mino, Mao Mizusaki, Kanako Chujo, Ryoko Kagawa, Hayamasa Yamaguchi, Norimitsu Kadowaki, Hiroaki Dobashi
Publikováno v:
BMC Rheumatology, Vol 8, Iss 1, Pp 1-9 (2024)
Abstract Background In 2020, Nintedanib (NTB), a tyrosine kinase inhibitor, was the first drug approved worldwide for treating progressive fibrosing interstitial lung disease (PF-ILD). This study evaluated the efficacy and safety of NTB in Japanese p
Externí odkaz:
https://doaj.org/article/ab06a17021b64148a94417838e84ddcd
Evaluation of fibroblast activation protein‐specific PET/CT in a patient with post‐COVID pneumonitis
Autor:
Khaled Musameh, Shane O'Brien, Roshane Mehboob, Thomas Butler, Zara Cunningham, Carol Buckley, Armin Atzinger, Torsten Kuwert, Patrick Mitchell, Seamas C. Donnelly
Publikováno v:
Respirology Case Reports, Vol 12, Iss 9, Pp n/a-n/a (2024)
Abstract Coronavirus disease 2019 (COVID‐19) often leads to a spectrum of pulmonary complications, including interstitial lung disease (ILD) with the potential for fibrotic sequelae. Assessing the presence of ongoing active inflammation versus esta
Externí odkaz:
https://doaj.org/article/dda1727f5b744a7199104eab2769fd11
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
ObjectivesInterstitial lung disease (ILD) is one of the common extramuscular involvement in idiopathic inflammatory myopathies (IIMs) (1). Several patients develop a progressive fibrosing ILD (PF-ILD) despite conventional treatment, resulting in a pr
Externí odkaz:
https://doaj.org/article/89bb7c79cef1485eb9afcf02462b84cd
Autor:
David Singer, Benjamin Chastek, Andrew Sargent, Jonathan C. Johnson, Sharash Shetty, Craig Conoscenti, Elana J. Bernstein
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Many types of interstitial lung diseases (ILDs) may transition to progressive chronic-fibrosing ILDs with rapid lung function decline and a negative survival prognosis. In real-world clinical settings, forced vital capacity (FVC)
Externí odkaz:
https://doaj.org/article/e919b0b08e3d40198bf8d0c0cb27be93
Autor:
Miwa Kamatani, Minoru Inomata, Akari Misumi, Ken Ito, Takashi Maeda, Haruka Chin, Yu Ito, Keita Sakamoto, Nobuyasu Awano, Naoyuki Kuse, Yoshiaki Furuhata, Yuan Bae, Hiroaki Sugiura, Tamiko Takemura, Takehiro Izumo
Publikováno v:
Respiratory Medicine Case Reports, Vol 50, Iss , Pp 102036- (2024)
Airway-centered fibroelastosis is characterized by peribronchovascular fibroelastosis, predominantly in the upper lobes, with little-to-no pleural involvement. In this study, we describe two cases of airway-centered fibroelastosis diagnosed based on
Externí odkaz:
https://doaj.org/article/3375839ba5c54ad1aa008e6ec3a4b898
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Fibrosing interstitial lung disease (F-ILD) is a major public health concern due to its poor prognosis. Recent clinical evidence shows that antifibrotic approaches such as pirfenidone and nintedanib provide better clinical outcome
Externí odkaz:
https://doaj.org/article/272b46e81dbf427ba824b955f672237f
Autor:
Julien Guiot, Makon-Sébastien Njock
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Externí odkaz:
https://doaj.org/article/d14624fbf8de4e72ba941ff297dfc957
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Reoto Takei, Toshiaki Matsuda, Jun Fukihara, Hajime Sasano, Yasuhiko Yamano, Toshiki Yokoyama, Kensuke Kataoka, Tomoki Kimura, Atsushi Suzuki, Taiki Furukawa, Junya Fukuoka, Takeshi Johkoh, Yasuhiro Kondoh
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundHealth-related quality of life (HRQoL) captures different aspects of the fibrotic interstitial lung disease (FILD) evaluation from the patient’s perspective. However, little is known about how HRQoL changes in patients with non-idiopathic
Externí odkaz:
https://doaj.org/article/6580ce86b4594a6d8c721d4671302e85
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Progressive fibrosing interstitial lung diseases (PF-ILDs) represent a group of conditions of both known and unknown origin which continue to worsen despite standard treatments, leading to respiratory failure and early mortality. Given the potential
Externí odkaz:
https://doaj.org/article/87de1fe6131c43fb9040033bc05c9c28